Medication safety and dosing
MedAware
Medication safety monitoring platform that uses machine learning and outlier detection to flag patient- and provider-specific medication risks.
Last updated: June 5, 2026
Back to directoryDreaMed endo.digital medical AI product profile
Cloud-based diabetes decision-support platform that uses patient glucose and insulin data to generate clinician-reviewed insulin treatment recommendations.
Medication safety and dosing
Best fit
Diabetes programs that need specialist-level insulin titration support across endocrinology, primary care, remote monitoring, and population-management workflows.
- Primary use case
- FDA-cleared diabetes clinical decision support for insulin treatment recommendations, glucose-device data review, remote diabetes management, and care-plan standardization
- Audience
- Endocrinology clinics, diabetes centers, primary care groups, remote patient monitoring teams, and health systems managing insulin-treated diabetes
- Risk level
- High
- Pricing signal
- Enterprise clinic, health-system, and diabetes-program pricing; request current module, device, integration, regulatory, and support terms.
- Official sources
- 4 official sources
Compare within workflow: Medication safety and dosing · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating DreaMed endo.digital as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as high-risk, regulated diabetes clinical decision support. Verify the exact cleared device version, indications, patient population, insulin regimen, device compatibility, and clinician-review requirements before use. |
|---|---|
| Privacy | Review diabetes device data, patient app data, EHR integration, PHI, audit logs, SOC 2 and HIPAA claims, BAA terms, retention, support access, and any data use for product improvement. |
| Evidence | Validate FDA summaries, clinical evidence, local patient mix, unsupported-regimen exclusions, clinician agreement, override rates, glycemic outcomes, and adverse-event monitoring. |
| Workflow | Best deployed with endocrinology and pharmacy governance, clear insulin-change signoff, device-data quality checks, remote-monitoring protocols, and documentation of accepted or rejected recommendations. |
Where DreaMed endo.digital fits
DreaMed describes endo.digital as a cloud-based SaaS diabetes care pathway with FDA-cleared algorithm intelligence for personalized insulin treatment recommendations; FDA records list K232722 for the endo.digital Platform, and AccessGUDID describes the earlier Advisor Pro workflow as physician-reviewed insulin therapy adjustment recommendations from CGM, SMBG, pump, and meal data.
Not for: Autonomous insulin changes, emergency glycemic management, unsupported devices or insulin regimens, or use without healthcare-professional review and local protocol governance.
What to verify before using DreaMed endo.digital
- Which product name and clearance are in scope for the deployment, including Advisor Pro history, endo.digital Platform K232722, and the intended patient population.
- Supported devices, insulin regimens, pump or injection workflows, CGM or SMBG data requirements, EMR integration, and downtime or data-quality procedures.
- HIPAA, SOC 2, BAA, patient mobile app, device-data, EHR, prompt or algorithm-log, retention, hosting, and support-access controls.
- Local clinician agreement, A1c and time-in-range outcomes, false or unsafe recommendations, override documentation, patient messaging, and accountability for final insulin changes.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- dreamed.ai / product
- dreamed.ai / about-us
- www.accessdata.fda.gov / scripts / cdrh
- accessgudid.nlm.nih.gov / devices / 07290017735016
Related medical AI products
Medication safety and dosing
DrFirst Clinical-Grade AI
Clinical-grade AI from DrFirst that uses NLP and machine learning to normalize incomplete or free-text medication data for safer medication management.
Medication safety and dosing
DoseMeRx
Bayesian dosing platform for clinical practice that uses patient characteristics, drug concentrations, and validated pharmacokinetic models to support dose optimization.
Medication safety and dosing
InsightRX Nova
Precision dosing clinical decision-support platform that adapts dosing recommendations to patient data over time using model-informed methods.